Register Free
Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2231 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2231 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase II
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
A trial testing ALN-6400 injections to reduce heavy menstrual bleeding in women and girls with von Willebrand disease.
26 Oct 2026 NCT07575308
● Recruiting
Tensi+ European Post-Market Clinical Follow-Up
A study tracking how well a new electrical nerve stimulation device works for overactive bladder over one year in real clinical practice.
26 Oct 2026 NCT07205445
active not recruiting Phase III
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Crovalimab was as safe and effective as eculizumab in treating PNH patients already on complement inhibitor therapy.
26 Oct 2026 NCT04432584
● Recruiting Phase I / Phase II Diabetes / Metabolic
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
WVE-007 is a new injectable weight-loss drug being tested for safety and effectiveness in overweight and obese adults, with and without type 2 diabetes.
26 Oct 2026 NCT06842186
● Recruiting Cardiology / Cardiovascular
Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD)
Real world evidence study on the performance and safety of a nitric oxide generating dressing on the treatment of diabetic foot ulcers
26 Oct 2026 NCT07438951
● Recruiting Phase II Oncology
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
This is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell sarcoma (CCS).
26 Oct 2026 NCT06942442
active not recruiting Infectious Disease
Preventing Kidney Injury Using Carbon Dioxide as Contrast Medium in Patients With Peripheral Arterial Disease (PAD) and Chronic Kidney Disease (CKD) Having Arterial Intervention
CO2 contrast during leg artery surgery may protect kidneys better than standard dye in patients with kidney disease.
23 Oct 2026 NCT07891988
● Recruiting Phase III Rheumatology
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Study tested bimekizumab drug levels and safety in children with inflammatory arthritis conditions.
23 Oct 2026 NCT06668181
● Recruiting Neurology
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
Study collecting blood samples and routine clinical data from people with epilepsy to identify patterns in causes, genetics, and brain characteristics.
23 Oct 2026 NCT05632978
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer’s Disease
What is being tested: SAR448851, a novel once-daily oral medication, is being evaluated in a randomized, placebo-controlled Phase 2 trial to assess its efficacy…
23 Oct 2026 NCT07688213
● Recruiting Phase II Neurology
Prevent Cognitive Decline in GBA-associated Parkinson’s Disease
Treatment being tested: Prasinezumab, a monoclonal antibody, is being evaluated for its ability to slow or prevent cognitive decline in patients with Parkinson's disease…
23 Oct 2026 NCT07055087
● Recruiting Phase III Cardiology / Cardiovascular
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
What is being tested: MK-8748, a novel investigational therapy, is being compared against aflibercept (standard treatment) to evaluate its efficacy and safety in treating…
23 Oct 2026 NCT07705555
● Recruiting Phase III Oncology
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
What is being tested: Elritercept, a novel therapeutic agent, is being evaluated for its efficacy in reducing red blood cell (RBC) transfusion requirements in…
23 Oct 2026 NCT06499285
active not recruiting Phase III Oncology
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
A new cancer drug (sacituzumab tirumotecan) is being tested against standard treatment in advanced stomach cancer to see if it improves survival.
22 Oct 2026 NCT06356311
● Recruiting Respiratory / COPD / Asthma
ID93/GLA-SE Vaccination + BCG Challenge
Novel TB vaccine ID93/GLA-SE tested for safety and immune response in BCG-vaccinated and unvaccinated volunteers using aerosol challenge.
22 Oct 2026 NCT06670755
active not recruiting Phase III Cardiology / Cardiovascular
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
ALXN2220 drug tested against placebo in adults with heart amyloidosis, measuring death and heart-related events.
22 Oct 2026 NCT06183931
active not recruiting Phase II
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
Bezuclastinib plus standard care improved symptoms better than placebo in patients with indolent or smoldering systemic mastocytosis.
22 Oct 2026 NCT05186753
● Recruiting Mental Health / Psychiatry
Evaluation of a Brief Influencer-Delivered Body Image Video
A social media influencer delivers a 60-second video to improve body confidence in women, tested against a control video in an online trial.
22 Oct 2026 NCT07850037
● Recruiting Phase II
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
A drug called INCB000928 is tested against placebo in patients with fibrodysplasia ossificans progressiva to assess its effectiveness and safety.
22 Oct 2026 NCT05090891
● Recruiting Respiratory / COPD / Asthma
OPM- MEG in Non-immune And iMmune-medIated Neurological Disease
What is being tested: Optically Pumped Magnetometer (OPM)-MEG brain imaging technology to detect abnormal neural activity patterns in patients with immune-mediated neurological diseases (autoimmune…
22 Oct 2026 NCT07689682
● Recruiting Phase I Respiratory / COPD / Asthma
A 2-part Phase 1/2 Open-label Trial on ODM-212
What is being tested: ODM-212 is a novel therapeutic agent being evaluated through a structured phase 1/2 trial design, progressing from initial dose escalation…
22 Oct 2026 NCT07563738
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Treatment being tested: PF-07275315, a novel investigational medicine, is being evaluated for efficacy and safety in patients with moderate to severe COPD to address…
22 Oct 2026 NCT07363694
● Recruiting Phase III Cardiology / Cardiovascular
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Treatment Being Tested: AZD0120 (a novel consolidation therapy) is being compared against autologous stem cell transplantation (ASCT) as consolidation treatment in newly diagnosed multiple…
22 Oct 2026 NCT07735637
● Recruiting Phase III Cardiology / Cardiovascular
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
What is being tested: Two novel Factor XI inhibitors (REGN7508 and REGN9933) are being evaluated to reduce adverse vascular events in patients with Peripheral…
22 Oct 2026 NCT07318610
● Recruiting Cardiology / Cardiovascular
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
What is being tested: This Post Authorisation Safety Study (PASS) evaluates the incidence of cardiovascular and cerebrovascular adverse events in COPD patients newly initiating…
22 Oct 2026 NCT05652439
● Recruiting Phase II Oncology
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
What is being tested: The combination of two immunotherapy agents—porustobart and pembrolizumab—administered before surgery (neoadjuvant approach) in patients with resectable, microsatellite stable/proficient mismatch repair…
22 Oct 2026 NCT07808151
● Recruiting Phase I Oncology
A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3
What is being tested: MX006, a novel first-in-human B7-H3-targeted immunotherapy, is being evaluated in a Phase 1a/1b dose-escalation and dose-expansion study in patients with…
22 Oct 2026 NCT07807241
● Recruiting
Clinical Feasibility of the IMES Transradial Prosthesis
Implanted sensors tested to control a prosthetic arm fitted at the forearm using muscle signals.
21 Oct 2026 NCT04936789
active not recruiting
Safe and Timely Antithrombotic Removal (STAR) Registry
CytoSorb device use for removing blood-thinning drugs: real-world safety and effectiveness data collection.
21 Oct 2026 NCT05077124
● Recruiting Diabetes / Metabolic
Nutritional Supplementation on Physiological and Metabolic Markers in Females
Trial testing whether a 12-week supplement containing myo-inositol, berberine, cinnamon, and chromium improves body composition in women aged 38-55.
21 Oct 2026 NCT07615777
● Recruiting Women's Health
Retinal Imaging for Systemic Inflammation in Endometriosis
Eye scans may help identify systemic inflammation markers in women with endometriosis compared to those without the condition.
21 Oct 2026 NCT07232485
active not recruiting
Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome
Daily hay-aged cheese versus cheddar over 12 weeks may lower cholesterol through gut bacteria changes in elevated cholesterol patients.
21 Oct 2026 NCT07351175
● Recruiting Cardiology / Cardiovascular
Arterial Stiffness and Endothelial Function in Heart Failure
What is being tested: The study investigates how arterial stiffness and endothelial dysfunction contribute to poor outcomes in heart failure patients, aiming to identify…
21 Oct 2026 NCT07713719
● Recruiting Neurology
MediPD: An Online Mediterranean Diet Program for People Living With Parkinson’s Disease
What is being tested: MediPD, an online Mediterranean diet intervention programme designed specifically for people living with Parkinson's disease, with evaluation of its acceptability,…
21 Oct 2026 NCT07838675
● Recruiting Cardiology / Cardiovascular
Robotic RVO Trial: Robot-assisted Retinal Vein Cannulation in Patients With Retinal Vein Occlusions
What is being tested: Robot-assisted retinal vein cannulation to mechanically address the underlying blood clot in retinal vein occlusions, rather than treating secondary complications…
21 Oct 2026 NCT07820761
● Recruiting Cardiology / Cardiovascular
Quality of Pediatric Resuscitation in a Multicenter Collaborative
What is being tested: The study examines whether specific chest compression mechanics during pediatric cardiac arrest (rate, depth, flow fraction, and compression release quality)…
21 Oct 2026 NCT02708134
● Recruiting Cardiology / Cardiovascular
Prevail Global Study
What is being tested: The Prevail Global Study evaluates the clinical safety and efficacy of the Prevail Drug-Coated Balloon (DCB), a therapeutic device designed…
21 Oct 2026 NCT06535854
● Recruiting Phase I Oncology
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Drug Being Tested: PF-07220060, a novel investigational agent being evaluated both as monotherapy and in combination with endocrine therapy for advanced solid tumors, with…
21 Oct 2026 NCT04557449
active not recruiting Phase I / Phase II Oncology
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
BT8009-100 Trial Summary First-in-human trial testing BT8009 alone and with pembrolizumab in advanced cancers expressing Nectin-4 protein.
20 Oct 2026 NCT04561362
active not recruiting Phase III
Study to Learn If Tofersen (BIIB067) Can Delay ALS Symptoms and About Its Safety in Adults With a SOD1 Gene Mutation Who Have Not Yet Developed ALS Symptoms
Trial testing whether tofersen can delay symptom onset in adults with SOD1 gene mutation before ALS develops.
20 Oct 2026 NCT04856982
● Recruiting
Mineral-Infused Clothing for Recovery From Muscle Soreness and Muscle Damage After Exercise
Trial testing whether mineral-infused clothing improves leg muscle strength recovery 72 hours after intense exercise in healthy young adults.
20 Oct 2026 NCT07873866
active not recruiting Phase III Oncology
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
Belzutifan compared to everolimus for advanced kidney cancer, testing if belzutifan improves survival and delays disease progression.
20 Oct 2026 NCT04195750
active not recruiting Cardiology / Cardiovascular
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
COMPLETE-2 Trial Summary Using pressure measurements to guide treatment of extra heart blockages during heart attacks reduces complications compared to angiography alone.
20 Oct 2026 NCT05701358
● Recruiting Phase I Respiratory / COPD / Asthma
A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
What is being tested: RO7830698, a novel therapeutic agent, is undergoing evaluation for safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamic effects at single and multiple…
20 Oct 2026 NCT07822334
● Recruiting Neurology
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson’s Disease
Intervention being tested: Ginger supplementation as a potential therapeutic agent to increase ghrelin levels in patients with Parkinson's disease (PD) and REM Sleep Behaviour…
20 Oct 2026 NCT07882108
● Recruiting Phase II Oncology
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
The goal of this clinical trial is to learn if using a liver-directed therapy with high dose chemotherapy followed by approved cancer treatment to…
20 Oct 2026 NCT06607458
● Recruiting Oncology
Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
Background and Study Aims: Melanoma is the most dangerous form of skin cancer, and early detection is crucial for improving patient outcomes. Over 90%…
20 Oct 2026 NCT07883954
● Recruiting Diabetes / Metabolic
A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists
Ubiquinol supplement versus placebo to reduce fatigue and preserve muscle strength in adults taking GLP-1 weight loss medications.
19 Oct 2026 NCT07789106
● Recruiting Phase III
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Riliprubart compared to standard IVIg treatment in adults with CIDP over 109 weeks.
19 Oct 2026 NCT06290141
active not recruiting Phase III Cardiology / Cardiovascular
A Study of Rusfertide in Adults With Polycythemia Vera (PV)
Rusfertide reduced the need for blood removal in polycythemia vera patients by limiting iron availability for red blood cell production.
19 Oct 2026 NCT05210790